MODULATION BY BENZO[A]PYRENE OF EPIDERMAL GROWTH-FACTOR RECEPTORS, CELL-PROLIFERATION, AND SECRETION OF HUMAN CHORIONIC-GONADOTROPIN IN HUMAN PLACENTAL CELL-LINES
Ly. Zhang et al., MODULATION BY BENZO[A]PYRENE OF EPIDERMAL GROWTH-FACTOR RECEPTORS, CELL-PROLIFERATION, AND SECRETION OF HUMAN CHORIONIC-GONADOTROPIN IN HUMAN PLACENTAL CELL-LINES, Biochemical pharmacology, 50(8), 1995, pp. 1171-1180
Clinical observations indicate that maternal cigarette smoking has sig
nificant detrimental effects on fetoplacental development. The present
study used human trophoblastic choriocarcinoma cell lines of placenta
l origin to investigate the effects of benzo[a]pyrene (BaP) on epiderm
al growth factor (EGF) receptors, cell proliferation and human chorion
ic gonadotropin (hCG) secretion. BaP decreased I-125-EGF binding and E
GF receptor protein in a concentration-related manner in both BeWo and
JEG-3 cell lines. The steady-state level of EGF receptor mRNA, howeve
r, was not changed significantly by BaP in either cell line. Cell prol
iferation was unchanged or slightly increased following exposure to 10
and 50 mu M BaP in the presence of serum, whereas proliferation progr
essively decreased in cells exposed under serum-free conditions. The m
itogenic effect of EGF was inhibited by cotreatment with BaP in both c
ell lines. Further study of trophoblast endocrine function showed that
both basal and EGF-stimulated secretion of hCG was reduced significan
tly by BaP exposure in BeWo cells, whereas no adverse effect was seen
in JEG-3 cells. Finally, cytochrome P450 1A1 (CYP1A1) was induced in a
concentration-dependent manner by BaP in both cell lines. Thus, data
indicate that the BaP-mediated loss of EGF receptors alters trophoblas
t proliferation and endocrine function, and that different mechanisms
may be involved in the regulation of hCG secretion in BeWo and JEG-3 c
ells. in addition, this study supports the feasibility of using the Be
Wo and JEG-3 trophoblastic choriocarcinoma cell lines to investigate b
iomarkers and mechanisms of placental toxicity.